SMARCA1 Antibody (Rabbit mAb) [N5C5]

CatNo: F6203

    Application: Reactivity:
    • Lane 1: SW620, Lane 2: Saso2, Lane 3: HT29, Lane 4: Saso2
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    SDS-PAGE の分離ゲルの推奨濃度:5%

    使用情報

    Dilution
    1:1000
    1:100
    Application
    WB, IP
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human, Monkey
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    121 kDa
    ポジティブコントロール LN18 cells; SW620 cells; HeLa cells; HT-29 cells; Saos-2 cells; OVCAR8 cells; COS-7 cells; PANC-1 cells
    ネガティブコントロール

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use primary antibody dilution buffer to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

    Datasheet & SDS

    生物学的記述

    Specificity
    SMARCA1 Antibody (Rabbit mAb) [N5C5] detects endogenous levels of total SMARCA1 protein.
    タンパク質の局在
    細胞質、細胞核
    Uniprot ID
    P28370
    Clone
    N5C5
    Synonym(s)
    ATP-dependent helicase SMARCA1 | DKFZp686D1623 | FLJ41547 | global transcription activator homologous sequence | hSNF2L | ISWI | Nucleosome-remodeling factor subunit SNF2L | NURF140 | Probable global transcription activator SNF2L1 | SMARCA1 | SMCA1 | SNF2-like 1 | SNF2L | SNF2L1 | SNF2LB | SNF2LT | sucrose nonfermenting 2-like protein 1 | SWI | SWI/SNF related | matrix associated | actin dependent regulator of chromatin | subfamily a | member 1 | SWI/SNF-related matrix-associated actin-dependent regulator of chromatin a1 | SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 1 | SWI2
    Background
    SMARCA1 (also known as SNF2L) is a mammalian imitation switch (ISWI) family ATPase and the energy‑transducing core of specific chromatin remodeling complexes that reposition nucleosomes to generate ordered arrays and regulate access to DNA during replication, transcription and repair. The protein contains canonical helicase ATP‑binding and helicase C‑terminal domains, as well as a SANT domain and ISWI‑type regulatory elements that couple ATP hydrolysis to DNA- and nucleosome-dependent sliding of histone octamers, and alternative splicing produces at least two isoforms, one catalytically inactive that forms non-remodeling complexes and one helicase-active isoform that functions as the catalytic subunit in ISWI assemblies such as NURF and CERF. Within the NURF (nucleosome-remodeling factor) complex, SMARCA1 collaborates with the large subunit BPTF and accessory factors to slide edge- and center-positioned nucleosomes along DNA and to bind promoters of Engrailed homeobox genes En1 and En2, positively regulating their expression and thereby supporting brain development and neurite outgrowth in the mid–hindbrain region. NURF-dependent chromatin remodeling by SMARCA1 also influences T‑cell maturation from thymocytes by altering chromatin structure at genes required for T‑cell development, and genetic studies show that BPTF, the largest NURF subunit, is essential for proper differentiation of mesoderm, endoderm and ectoderm lineages, implicating SMARCA1-containing NURF in germ layer formation during mouse embryogenesis. SMARCA1 further participates in the CECR2-containing remodeling factor (CERF) complex, where it forms tissue-specific assemblies with CECR2 and the ISWI ATPase SMARCA5; CERF complexes in embryonic stem cells and testis remodel chromatin in an ATP-dependent manner, and loss-of-function mutations in Cecr2 cause the neural tube defect exencephaly, genetically linking SMARCA1–CECR2 remodeling activity to neurulation and neural tube closure. Pan-cancer bioinformatic analyses classify SMARCA1 as a chromatin remodeler that modulates cell transition from committed progenitors to differentiated states, and although SMARCA1 alterations are relatively infrequent compared with SWI/SNF ATPases like SMARCA4, expression and copy-number changes in SMARCA1 correlate in some carcinomas with proliferative signals and immune-related pathways, suggesting that SMARCA1-dependent nucleosome spacing and promoter accessibility contribute to oncogenic transcriptional programs in a context-dependent manner.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください